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Identification of 25-hydroxyvitamin D3 1a-hydroxylase gene
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Identification of 25-hydroxyvitamin D3 1a-hydroxylase gene mineral metabolism [1]. In addition, this hormone has
expression in macrophages. multiple effects on cells of the immune system [2]. 1,25-
Background. The 25-hydroxyvitamin D3 1a-hydroxylase (OH)2D3 induces differentiation of several human cell(1a-hydroxylase) is almost exclusively expressed in the kidney.
lines of the monocytic lineage and of normal humanHowever, 1a-hydroxylase activities have been observed in
some extrarenal tissues, including inflammatory cells of the hematopoietic cells. The hormone modulates various
monocyte/macrophage lineage. In sarcoidosis, macrophage 1a- functions of monocytes/macrophages, such as chemo-
hydroxylase causes overproduction of 1,25-(OH)2D3, resulting taxis, hydrogen peroxide production, antigen presenta-in hypercalcemia. In this study, we investigated the regulation
tion, and secretion of prostaglandin E2, and influencesof macrophage 1a-hydroxylase at a molecular level.
Methods. We used the human monocytic cell line THP-1, the activity of T and B lymphocytes [3–8].
which can be differentiated into macrophage-like cells by treat- In the formation of 1,25-(OH)2D3, 25-hydroxyvitamin
ment with phorbol ester. The expression of 1a-hydroxylase in D3 1a-hydroxylase (1a-hydroxylase) is the key enzymeTHP-1 cells was examined by Northern blotting and immu-
in the determination of 1,25-(OH)2D3 levels. 1a-Hydrox-noblotting using an antibody raised against a synthetic peptide
ylase is almost exclusively expressed in the kidney; how-corresponding to the 14 C-terminal amino acids of 1a-hydroxy-
lase. We investigated the regulation of 1a-hydroxylase mRNA ever, 1a-hydroxylase activities have been observed in
expression by RNase protection assay. some extra-renal tissues. Placenta, bone cells, keratino-
Results. Northern blot and immunoblot analyses confirmed
cytes, and macrophages from the alveolar space, perito-the expression of 1a-hydroxylase in THP-1 cells at the mRNA
neal cavity, and bone marrow have been reported toand protein levels. Although parathyroid hormone and calcito-
nin, known stimulators of renal 1a-hydroxylase, did not affect synthesize 1,25-(OH)2D3 in vitro [9–15]. The local pro-
the expression of 1a-hydroxylase mRNA, 8-Br-cAMP (5 3 duction of the active metabolite of vitamin D in target
1024 mol/L) increased the expression of 1a-hydroxylase mRNA
organs suggests an autocrine/paracrine role for 1,25-in THP-1 cells (198 6 9%). 1,25-(OH)2D3, known as a suppres-
(OH)2D3 in these tissues. Extra-renal 1,25-(OH)2D3 pro-sor of renal 1a-hydroxylase, did not affect the expression of
1a-hydroxylase mRNA. By contrast, 1,25-(OH)2D3 markedly duction does not contribute to systemic 1,25-(OH)2D3
increased the expression of 25-hydroxyvitamin D3 24-hydroxy- concentrations under physiological conditions. However,
lase mRNA. Interferon-g (2000 IU/mL) increased the expres-
in pregnancy [16] or in some pathological states, extrarenalsion of 1a-hydroxylase mRNA in differentiated THP-1 cells
1a-hydroxylase contributes to circulating 1,25-(OH)2D3.(922 6 25%).
Conclusions. The present results suggest that 1a-hydroxy- Hypercalcemia occurs in about 10% of the patients with
lase activity in macrophages is mediated by the same enzyme sarcoidosis [17]. Abnormal calcium metabolism is due
as in kidney. Interferon-g treatment increases macrophage 1a-
to dysregulated production of 1,25-(OH)2D3 by activatedhydroxylase levels via directly increasing gene expression of
1a-hydroxylase in macrophages trapped in pulmonarythis enzyme.
alveoli and granulomatous inflammation [12, 18].
The metabolic control of 1a-hydroxylase activity in
macrophages is different from that in renal epithelial cells.The active form of vitamin D3, 1,25-dihydroxyvitamin
D3 [1,25-(OH)2D3], is an important regulator of bone and Renal 1a-hydroxylase activity is under stringent regula-
tion by parathyroid hormone (PTH), calcitonin, calcium,
phosphorus, and 1,25-(OH)2D3 itself [1]. In contrast, mac-Key words: vitamin D3, interferon-g, THP-1 cells, RNase protection
assay. rophage 1a-hydroxylase is relatively immune to stimula-
tion by calcium or PTH or to feedback inhibition by 1,25-
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question of whether the macrophage 1a-hydroxylase is with a [32P]-labeled probe prepared from a full-length
human 1a-hydroxylase cDNA. A final high-stringencythe same enzyme as the renal 1a-hydroxylase.
wash was performed at 508C in 0.1 3 standard salineHuman monocytic THP-1 cells provide a valuable
citrate (SSC), 0.1% sodium dodecyl sulfate (SDS), andmodel for study of the regulation of 1a-hydroxylase in
the blot was exposed to a BAS Imaging Plate (Fuji Photomacrophages. After treatment with phorbol esters, THP-1
Film, Tokyo, Japan). The blot was normalized by probingcells differentiate into macrophage-like cells, which
with b-actin. In Northern blot analysis of vitamin Dmimic native monocyte-derived macrophages in several
receptor (VDR), we used a [32P]-labeled probe preparedrespects [21]. Phorbol ester-differentiated THP-1 cells
from a human VDR cDNA [24].constitutively expressed 1a-hydroxylase activity, and
1,25-(OH)2D3 production increased 30-fold in response Antibodiesto interferon-g [22].
Rabbit polyclonal antibody was raised against a syn-We recently cloned a 1a-hydroxylase cDNA from hu-
thetic peptide corresponding to the 14 C-terminal aminoman kidney [23]. This enabled us to investigate the mac-
acids of 1a-hydroxylase (LVPERSINLQFLDR). A cys-rophage 1a-hydroxylase at a molecular level. In this study,
teine residue was attached to the N-terminus of the pep-we examined 1a-hydroxylase expression in THP-1 cells
tide to introduce SH residue for coupling. The 15-aminoat the mRNA and protein levels and the effects of PTH,
acid CLVPERSINLQFLDR was synthesized by the f-moccalcitonin, cAMP, 1,25-(OH)2D3, and interferon-g on the
method. The synthetic peptide conjugated with keyholeexpression of 1a-hydroxylase mRNA in these cells.
limpet hemocyanin by sulfo-MBS method was used to
immunize two New Zealand white rabbits with Freund’s
METHODS complete adjuvant (first injection) or incomplete adju-
vant (from second injection). After five injections, a suf-Reagents
ficient increase of the antibody titer was confirmed by8-Br-cAMP, phorbol 12-myristate 13-acetate (PMA),
enzyme-linked immunosorbent assay (ELISA), and se-and actinomycin D were purchased from Sigma Chemical
rum was collected. Specific antibodies were prepared(St. Louis, MO, USA). Human PTH (1-34) and salmon
from the antiserum by affinity column chromatographycalcitonin was purchased from Bachem Feinchemikalien
using the antigen peptide coupled to FMP-activated Cel-AG (Bubendorf, Switzerland). 1,25-(OH)2D3 was pur- lulofine (Seikagaku Kogyo, Tokyo, Japan).chased from Duphar (Weesp, The Netherlands). Recom-
binant human interferon-g was purchased from Gen- Immunoblotting
zyme Corporation (Cambridge, MA, USA). THP-1 cells were washed with PBS and treated with
10% (volume/volume) trichloroacetic acid for 15 minutesCell culture
on ice. The precipitated proteins were collected by cen-
Human monocytic THP-1 cells (American Type Cul- trifugation, dissolved in 80 mL of 9 mol/L urea containing
ture Collection TIB202; ATCC, Rockville, MD, USA) 2% (volume/volume) Triton X-100 and 1% (weight/vol-
were grown in RPMI 1640 supplemented with 10% fetal ume) dithiothreitol, and disrupted by sonication. Then
bovine serum (FBS), 100 U/mL penicillin, and 100 mg/mL 20 mL of loading buffer containing 10% (weight/volume)
streptomycin. THP-1 cells were differentiated by expo- lithium dodecyl sulfate and Bromophenol blue were
sure to 160 nmol/L PMA for 24 hours and were then added to the solubilized protein. These samples, corre-
washed twice with phosphate-buffered saline (PBS) and sponding to approximately 2 3 105 cells of THP-1 cells
once with serum-free media. In all experiments, serum were subjected to SDS-polyacrylamide gel electrophore-
was removed from the media 12 hours before the addi- sis (SDS-PAGE) followed by immunoblotting. SDS-
tion of reagents. THP-1 cells were incubated with re- PAGE was performed as described by Laemmli [25] on
agents in RPMI 1640 containing 0.1% fatty acid-free 7.5% gels. Proteins were transferred onto a Hybond ECL
bovine serum albumin for 24 hours. After medium was nitrocellulose filter (Amersham Pharmacia Biotech AB,
removed, the cells were washed with PBS, and RNA or Uppsala, Sweden) and probed with anti–1a-hydroxylase
protein was prepared. antibody. Bound antibodies were visualized by an ECL
Western blotting system (Amersham Pharmacia Biotech
Northern blotting AB). COS-7 cells transfected with human 1a-hydroxylase
Poly (A)1 RNA was prepared using Micro-Fast Track cDNA were used as a positive control. To determine
kit (Invitrogen, Carlsbad, CA, USA) from THP-1 cells. antigen specificity, the antibody solutions were preab-
Approximately 2 mg of poly (A)1 RNA were denatured sorbed with the antigen peptide.
with glyoxal and dimethyl sulfoxide, separated on a 1%
Riboprobesagarose gel, and blotted onto a nylon membrane. The
blot was hybridized for 18 hours in ExpressHyb hybrid- DNA fragments corresponding to bases 1073 to 1354
of human 1a-hydroxylase cDNA [23], bases 1049 to 1421ization solution (Clontech, Palo Alto, CA, USA) at 688C,
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of human 25-hydroxyvitamin D3 24-hydroxylase cDNA GAGA-39 for 1a-hydroxylase, and 59-ACCATTGGCA
[26], and bases 748 to 894 of human b-actin cDNA [27] ATGAGCGGTTCCGCT-39 for b-actin) that lies within
were amplified from reverse-transcribed human kidney the target sequence between the two original primers. The
cDNA and subcloned into plasmid pT7Blue-T vector band intensities were measured by densitometric scanning
(Novagen, Madison, WI, USA). All constructs were con- and were normalized with the band intensities of b actin.
firmed by sequence analysis. Plasmids were linearized Three independent experiments were performed.
with EcoR I, and antisense RNA probes were labeled
with [a-32P]UTP using T7 RNA polymerase. The synthe- Statistical analysis
sized full-length cRNAs were gel purified from a poly- The results were expressed as a percentage of the con-
acrylamide gel and then subjected to RNase protection trol values or the maximum stimulation. Data are ex-
assay. The sizes of the protected fragments was 282 bp pressed as mean 6 SEM. Statistical significance was eval-
for the human 1a-hydroxylase, 347 bp for the human uated by Student’s t-test or one-way analysis of variance
24-hydroxylase, and 147 bp for the human b-actin. (ANOVA) with a Scheffe’s post hoc test, as appropriate.
Differences were considered significant when P , 0.05.RNase protection assay
Total RNA was extracted from THP-1 cells using ISO-
GEN (Nippon Gene, Tokyo, Japan). The RNase protec- RESULTS
tion assay was carried out according to the manufactur- Northern blot analysis
er’s protocol to an RPA II kit (Ambion, Austin, TX,
We recently showed that 1a-hydroxylase mRNA isUSA). For each experiment, 10 mg of total RNA and
almost exclusively expressed in the kidney in humansthree [32P]-labeled riboprobes were mixed and coprecipi-
[23]. We examined renal 1a-hydroxylase mRNA expres-tated. After centrifugation, each sample was suspended
sion in human monocytic THP-1 cells by Northern blotin 20 mL of hybridization buffer, heated to 958C for three
analysis using a 1a-hydroxylase cDNA cloned from hu-minutes, and then hybridized at 458C for 12 to 18 hours.
man kidney as a probe. 1a-Hydroxylase gene transcriptsThe hybridization mixture was digested with 200 mL of
were not detected in normal THP-1 cells (Fig. 1, lane 1).RNase A (1.25 U/mL) and RNase T1 (50 U/mL) at 378C
When THP-1 cells were differentiated by incubation withfor 30 minutes, followed by precipitation. The protected
160 nmol/L PMA for 24 hours, followed by stimulationfragments were resolved on a 5% polyacrylamide gel
containing 8 mol/L urea. The gel was transferred to chro- by 2000 IU/mL interferon-g, a 2.5 kb band consistent
matography paper and exposed to a BAS Imaging Plate. with 1a-hydroxylase mRNA was detected (Fig. 1, lane 2).
Band intensities were quantitated using a FUJIX BIO-
Immunoblot analysisImaging Analyzer BAS 2000 (Fuji Photo Film) and nor-
malized to the signal generated by the constitutively ex- We generated a polyclonal antibody specific for 1a-
pressed b-actin gene. Each experiment was conducted hydroxylase to examine 1a-hydroxylase protein expres-
at least four times. sion. This antibody was produced against a synthetic pep-
tide corresponding to the 14 C-terminal amino acids ofRT-PCR and Southern blotting
1a-hydroxylase (LVPERSINLQFLDR), which is unique
To examine the effect of actinomycin D on the inter- for 1a-hydroxylase. The specificity of the antibody was
feron-g–induced 1a-hydroxylase mRNA expression, we tested by immunoblot analysis with homogenate prepared
employed reverse transcription-polymerase chain reaction from COS-7 cells transfected with human 1a-hydroxylase
(RT-PCR) and Southern blotting for mRNA quantitation. cDNA. The antibody recognized a single major band at
THP-1 cells were incubated with 2000 IU/mL of inter-
approximately 55 kD (Fig. 2, lane 1). The band was
feron-g in the presence or absence of 10 mg/mL of actino-
abolished by pretreatment of the antibody with the anti-mycin D for six hours. Messenger RNA for 1a-hydroxy-
gen peptide (Fig. 2, lane 6). The differentiated THP-1lase and b-actin were amplified by PCR using the specific
cells did not show any band (Fig. 2, lanes 2 and 3). Whenprimer sets (59-GGAGTGGACACGGTGTCCAA-39 and
differentiated THP-1 cells were incubated with 200059-ACACAGAGTGACCAGCGTATT-39 for 1a-hydroxy-
IU/mL of interferon-g for 24 hours, a 55 kD band consis-lase, and 59-TGGAGAAGAGCTACGAGCTG-39 and
tent with 1a-hydroxylase protein was detected (Fig. 2,59-ACTTCATGATGGAGTTGAAGG-39 for b-actin).
lanes 4 and 5). The band was abolished by pretreatmentFor the linear relationship between the amount of RNA
of the antibody with the antigen peptide (Fig. 2, lanes 9and PCR product, we employed 28 cycles for 1a-hydrox-
and 10). We could not see any band after incubationylase and 18 cycles for b-actin. Analysis of PCR products
with 1028 mol/L 1,25(OH)2D3 for 24 hours (Fig. 2, lanewas performed by agarose gel electrophoresis followed
13). This finding supports that our antibody did not cross-by Southern blotting and then hybridized to an internal
oligonucleotide (59-GTCCAGACAGCACTCCACTCA react with 25-hydroxyvitamin D3 24-hydroxylase protein.
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Effect of PTH, calcitonin, and cAMP
Parathyroid hormone and calcitonin are known stimu-
lators of renal 1a-hydroxylase. However, 1027 mol/L PTH
did not stimulate 1a-hydroxylase mRNA expression in
differentiated THP-1 cells, and 1027 mol/L calcitonin also
had no significant effect (Fig. 3B). The effects of PTH
and calcitonin are exerted in part through the protein
kinase A (PKA) pathway. We found that 5 3 1024 mol/L
of 8-Br-cAMP, a PKA activator, increased 1a-hydroxy-
lase mRNA levels (198 6 9%, N 5 4, P , 0.05; Fig. 3B).
We could not detect PTH receptor or calcitonin receptor
expression in THP-1 cell by RT-PCR (data not shown).
Effect of 1,25-(OH)2D3
The effect of 1,25-(OH)2D3, an important negative
regulator of renal 1a-hydroxylase, on 1a-hydroxylase
mRNA expression in undifferentiated and differentiated
THP-1 cells was examined. Even at a concentration of
1028 mol/L, 1,25-(OH)2D3 did not affect 1a-hydroxylase
mRNA expression (Fig. 4).
24-Hydroxylase is known to be responsible for 1,25-
(OH)2D3 inactivation. Under basal conditions, 24-hydrox-
ylase mRNA levels were undetectable. Incubation with
1028 mol/L 1,25-(OH)2D3 dramatically induced 24-hydrox-
ylase mRNA expression (Fig. 5). The responsiveness of
24-hydroxylase gene expression to 1,25-(OH)2D3 demon-Fig. 1. Northern blot analysis of 1a-hydroxylase expression. Two mi-
strates the presence of VDR in THP-1 cells. In addition,crogram of poly(A)1 RNA were separated on 1% agarose gel and
probed with 1a-hydroxylase cDNA (upper panel) or b-actin (lower Northern blot analysis for VDR showed that the differ-
panel). Lane 1, THP-1 cells, and lane 2, differentiated THP-1 cells entiated THP-1 cells expressed VDR receptor mRNA
incubated with 2000 IU/mL interferon-g for 24 hours. The relative
and that treatment with 2000 IU/mL of interferon-g didposition of size markers is indicated on the left.
not affect the mRNA expression of VDR (Fig. 6).
Effect of interferon-g
RNase protection assay Interferon-g is a macrophage-specific potent stimula-
1a-Hydroxylase is expressed at relatively low levels, tor of 1a-hydroxylase. Figure 7 shows the effects of incu-
and thus, we used RNase protection assay to measure bation of undifferentiated and differentiated THP-1 cells
more sensitively the regulation of 1a-hydroxylase mRNA with increasing amounts of interferon-g on the expres-
expression in THP-1 cells. Riboprobes for 1a-hydroxy- sion of 1a-hydroxylase mRNA. Interferon-g exerted a
lase, 24-hydroxylase, and b-actin were transcribed from dose-dependent stimulatory effect on the expression of
the DNA templates corresponding to bases 1073 to 1354 1a-hydroxylase mRNA in THP-1 cells. At a concentra-
of human 1a-hydroxylase cDNA [23], bases 1049 to 1421 tion of 2000 IU/mL, mRNA expression was increased
of human 24-hydroxylase cDNA [26], and bases 748 to (196 6 8%, N 5 4, P , 0.05; Fig. 7A). In differentiated
894 of human b-actin cDNA [27], respectively. The three THP-1 cells, the stimulatory effect of interferon-g was
probes detected signals for 1a-hydroxylase mRNA, 24- more obvious; it increased 1a-hydroxylase expression at
hydroxylase mRNA, and b-actin mRNA. a concentration of 2000 IU/mL (922 6 25%, N 5 4, P ,
0.05; Fig. 7B). The effect of interferon-g observed in
Effect of differentiation RNase protection assay was comparable with the results
First, 1a-hydroxylase mRNA expression along with obtained by Northern blot analysis and immunoblot
differentiation of THP-1 cells was examined. The 1a- analysis. In a time course study, the stimulatory effect
hydroxylase mRNA levels were low in undifferentiated of interferon-g was observed at 6 hours, and maximal
THP-1 cells. Upon differentiation by incubation with effect was observed at 24 hours (data not shown).
160 nmol/L PMA for 24 hours, 1a-hydroxylase mRNA To determine whether the regulation of the 1a-hydroxy-
expression was significantly increased (303 6 9%, N 5 4, lase mRNA expression by interferon-g occurs at a tran-
scriptional level, we examined the effect of the RNAP , 0.05; Fig. 3A).
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Fig. 2. Immunoblot analysis of 1a-hydroxy-
lase in THP-1 cells. Lanes 1, 6, and 11, homog-
enates from COS-7 cells transfected with 1a-
hydroxylase cDNA. Lanes 2, 3, 7, 8 and 12,
homogenates from differentiated THP-1 cells.
Lanes 4, 5, 9, and 10, homogenates from differ-
entiated THP-1 cells incubated with 2000 IU/mL
interferon-g for 24 hours. Lane 13, homoge-
nate from differentiated THP-1 cells incu-
bated with 1028 mol/L 1,25-(OH)2D3 for 24
hours. Immunoblot analysis probed with anti-
body against 1a-hydroxylase (lanes 1 through
5 and 11 through 13) or with the antibody
preabsorbed with the antigen peptide (lanes
6 through 10). The positions of molecular
weight markers are shown on the left.
Fig. 3. (A) Expression of 1a-hydroxylase
mRNA along with differentiation of THP-1
cells. Total RNA was extracted from undiffer-
entiated THP-1 cells or differentiated THP-1
cells (dTHP) by incubation for 24 hours with
PMA (160 nmol/L). (B) Effect of PTH, calci-
tonin, and cAMP on 1a-hydroxylase mRNA
expression. Total RNA was extracted from dif-
ferentiated THP-1 cells incubated for 24 hours
with vehicle (lane 1), 8-Br-cAMP (5 3 1024
mol/L; lane 2), PTH (1027 mol/L; lane 3), or
calcitonin (1027 mol/L; lane 4). In the upper
panels in A and B, autoradiograms of RNase
protection assay show protected fragments of
1a-hydroxylase (282 bp) and b-actin (147 bp)
mRNA. The lower panels in A and B show
quantitative analysis of 1a-hydroxylase gene
expression. Data were normalized using b-actin
mRNA and expressed as a percentage of the
control values. *P , 0.05 vs. control (N 5 4).
synthesis inhibitor actinomycin D on the induction of feron-g markedly suppressed 24-hydroxylase mRNA
expression induced by 1028 mol/L 1,25-(OH)2D3 in undif-1a-hydroxylase gene expression by interferon-g. Quanti-
tative RT-PCR showed the effect of interferon-g on 1a- ferentiated cells (92.3 6 4.1%, N 5 4, P , 0.05; Fig. 5A).
On the other hand, in differentiated THP-1 cells, 2000hydroxylase mRNA expression was abolished in the
presence of 10 mg/mL of actinomycin D (Fig. 8). This IU/mL of interferon-g suppressed it by only 53.5 6 2.4%
(N 5 4, P , 0.05; Fig. 5B). This indicates that the inhibi-indicates that the effect of interferon-g on 1a-hydroxy-
lase mRNA expression is, at least in part, a transcrip- tory effect of interferon-g on 1,25-(OH)2D3 action de-
creases as monocytes differentiate to macrophages. Wetional event.
examined the combined effect of interferon-g and 1,25-
Effect of combination of 1,25-(OH)2D3 and interferon-g (OH)2D3 on 1a-hydroxylase mRNA expression. Incuba-
tion with 1,25-(OH)2D3 (1028 mol/L) and interferon-gDusso et al demonstrated that interferon-g and 1,25-
(OH)2D3 had a cross-talk effect on the expression of hy- (2000 IU/mL) together was not significantly different to
that of interferon-g (2000 IU/mL) alone (Fig. 9).droxylases [22]. We observed that 2000 IU/mL of inter-
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Fig. 4. Effect of 1,25-(OH)2D3 on 1a-hydrox-
ylase mRNA expression. Total RNA was ex-
tracted from undifferentiated (A) or differen-
tiated (B) THP-1 cells incubated for 24 hours
with 1,25-(OH)2D3 (0, 10210, 1029, or 1028
mol/L). In the upper panels in A and B, auto-
radiograms of RNase protection assay show
protected fragments of 1a-hydroxylase (282
bp) and b-actin (147 bp) mRNA. The lower
panels in A and B show quantitative analysis
of 1a-hydroxylase gene expression. Data were
normalized using b-actin mRNA and were ex-
pressed as a percentage of the control values.
*P , 0.05 vs. control (N 5 4).
Fig. 5. Effect of 1,25-(OH)2D3 on 24-hydrox-
ylase mRNA expression. Total RNA was ex-
tracted from undifferentiated (A) or differen-
tiated (B) THP-1 cells incubated for 24 hours
with 1,25-(OH)2D3 (0, 10210, 1029, or 1028
mol/L) or 1,25-(OH)2D3 (1028 mol/L) together
with interferon-g (2000 IU/mL). In the upper
panels in A and B, autoradiograms of RNase
protection assay show protected fragments of
24-hydroxylase (347 bp) and b-actin (147 bp)
mRNA. The lower panels in A and B show
quantitative analysis of 24-hydroxylase gene
expression. Data were normalized using b-actin
mRNA and expressed as a percentage of the
values at the maximum stimulation. *P , 0.05
vs. control; §P , 0.05 vs. 1,25-(OH)2D3 (1028
mol/L) alone (N 5 4).
DISCUSSION rophage 1a-hydroxylase is mediated by the same gene
product as the renal 1a-hydroxylase.Human monocytic THP-1 cells provide the best current
THP-1 cells lacked the responsiveness for PTH or calci-model of mature monocytes [21]. Upon differentiation
tonin, which are known to be positive regulators for renalalong the monocytic lineage by treatment with phorbol
1a-hydroxylase. We can attribute this to an absence ofester, THP-1 cells acquire macrophage-like properties [28]
their receptors in THP-1 cells. It is known that the effectand 1a-hydroxylase activity [22]. In this study, Northern
of PTH is mediated through PKA, whereas the effect ofblot analysis demonstrated the expression of renal 1a-
calcitonin is mediated through both PKA and proteinhydroxylase gene transcripts in THP-1 cells. Immunoblot
kinase C (PKC). In the present study, 8-Br-cAMP, a PKAanalysis using 1a-hydroxylase–specific antibody showed
activator, induced 1a-hydroxylase mRNA expression inthe expression of 1a-hydroxylase protein in THP-1 cells.
THP-1 cells. Recently, we showed that the effect of calcito-Since the mRNA and protein are up-regulated by incuba-
nin on 1a-hydroxylase mRNA expression is mediatedtion with interferon-g, there is less possibility of cross-
through the PKC-signaling pathway, rather than throughreaction with other hydroxylases in the detection of
mRNA and protein. Thus, we can conclude that the mac- the PKA-signaling pathway [29]. Murayama et al also
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Fig. 8. Effect of actinomycin D on interferon-g-induced 1a-hydroxy-
lase mRNA expression. Total RNA was extracted from differentiated
THP-1 cells incubated for six hours with vehicle, interferon-g (2000 IU/
Fig. 6. Vitamin D receptor (VDR) mRNA expression in differentiated mL), or interferon-g (2000 IU/mL) and actinomycin D (10 mg/mL). In
THP-1 cells. Total RNA was extracted from differentiated THP-1 cells the upper panels, autoradiograms of RT-PCR/Southern blot analysis
incubated with vehicle or interferon-g (2000 IU/mL) for 24 hours. In show the bands of 1a-hydroxylase and b-actin mRNA. The lower panel
the upper panels, autoradiograms of Northern blot analysis show the shows quantitative analysis of 1a-hydroxylase gene expression. Data
bands of VDR and b-actin mRNA. The lower panel shows quantitative were normalized using b-actin mRNA and were expressed as a percent-
analysis of VDR gene expression. Data were normalized using b-actin age of the control values. *P , 0.05 vs. control (N 5 3).
mRNA and were expressed as a percentage of the control values.
Fig. 7. Effect of interferon-g on 1a-hydroxy-
lase mRNA expression. Total RNA was ex-
tracted from undifferentiated (A) or differen-
tiated (B) THP-1 cells incubated for 24 hours
with interferon-g (0, 20, 200, or 2000 IU/mL).
In the upper panels in A and B, autoradio-
grams of RNase protection assay show pro-
tected fragments of 1a-hydroxylase (282 bp)
and b-actin (147 bp) mRNA. The lower panels
in A and B show quantitative analysis of 1a-
hydroxylase gene expression. Data were nor-
malized using b-actin mRNA and were ex-
pressed as a percentage of the control values.
*P , 0.05 vs. control (N 5 4).
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Fig. 9. Effect of 1,25-(OH)2D3 on 1a-hydroxy-
lase mRNA expression in interferon-g–stim-
ulated THP-1 cells. Total RNA was extracted
from undifferentiated (A) or differentiated
(B) THP-1 cells incubated for 24 hours
with vehicle, interferon-g (2000 IU/mL), 1,25-
(OH)2D3 (1028 mol/L), or interferon-g (2000
IU/mL) together with 1,25-(OH)2D3 (1028
mol/L). In the upper panels in A and B, auto-
radiograms of RNase protection assay show
protected fragments of 1a-hydroxylase (282
bp) and b-actin (147 bp) mRNA. The lower
panels in A and B show quantitative analysis
of 1a-hydroxylase gene expression. Data were
normalized using b-actin mRNA and were ex-
pressed as a percentage of the control values.
*P , 0.05 vs. control (N 5 4).
reported PTH and calcitonin enhance 1a-hydroxylase increased 24-hydroxylase mRNA expression in THP-1
cells. This confirms that the 1,25-(OH)2D3 used in ourmRNA through the different signaling pathways [30].
Our study shows that interferon-g stimulates 1a-hydrox- experiments was active and that THP-1 cells expressed
VDR. In addition, we confirmed VDR mRNA expres-ylase activity at the level of gene expression. The main
intracellular signaling pathway after binding of inter- sion in THP-1 cells by Northern blot analysis. The ex-
pression of VDR mRNA was not affected by the treat-feron-g to its specific receptor is via the JAK-STAT path-
way. In response to interferon-g, Jak1 and Jak2 are acti- ment of interferon-g (2000 IU/mL). Dusso et al also
demonstrated that 1,25-(OH)2D3-VDR binding couldvated, followed by activation of Stat1a [31]. Activated
Stat1a forms Stat1a/Stat1a homodimers that bind a not account for the dramatic loss of 1,25-(OH)2D3 re-
sponsiveness in interferon-g–treated THP-1 cells [22].gamma-activating sequence (GAS; TTCNNNAA con-
sensus sequence) on the promoter region of the gene, These findings suggest that the decrease in production
of 1,25-(OH)2D3 in THP-1 cells might result from anand the transcription is activated [32]. We have cloned
the 59-flanking region of the 1a-hydroxylase gene. While increase in the expression of 24-hydroxylase but not from
a decrease in the expression of 1a-hydroxylase.no GAS was found, some homologous sequences were
identified in the 1.5 kb promoter region of 1a-hydroxy- In renal cells, 1,25-(OH)2D3 suppressed the expression
of 1a-hydroxylase gene at the transcriptional level. Mur-lase. We are planning to investigate the effect of inter-
feron-g on the promoter activity of 1a-hydroxylase gene ayama et al demonstrated that 1028 mol/L 1,25-(OH)2D3
suppress expression of 1a-hydroxylase mRNA by aboutusing a reporter gene system.
1,25-(OH)2D3 itself suppresses the enzyme activity of 80% in mouse renal proximal tubule cells, and found a
negative regulatory region for 1,25-(OH)2D3 located at1a-hydroxylase in renal cells. In macrophages, the inhibi-
tory effect of the 1,25-(OH)2D3 was less pronounced than around 20.5 kb in the human 1a-hydroxylase gene [33].
However, we and other groups observed that porcinethat in renal cells. A supranormal concentration (75
nmol/L) of 1,25-(OH)2D3 reduced 1,25-(OH)2D3 synthe- renal proximal tubule LLC-PK1 cells lack the 1,25-
(OH)2D3 transrepression system of the 1a-hydroxylasesis by only 20% in sarcoid macrophages [19], suggesting
an apparent lack of control in the 1a-hydroxylation reac- gene despite the presence of the 1,25-(OH)2D3 transacti-
vation system of 24-hydroxylase gene [34, 35]. Thesetion by 1,25-(OH)2D3 in sarcoid macrophages. In the
present study, we failed to demonstrate any inhibitory findings suggest that the 1,25-(OH)2D3 transactivation
system is conserved, whereas the 1,25-(OH)2D3 transre-effect of 1,25-(OH)2D3 on 1a-hydroxylase mRNA ex-
pression in THP-1 cells. Even a concentration of 1027 pression system was lost in THP-1 and LLC-PK1 cells.
The majority of studies have examined the activationmol/L 1,25-(OH)2D3 did not suppress expression (data
not shown). The addition of 1,25-(OH)2D3 to interferon- of gene expression by 1,25-(OH)2D3. Vitamin D3 re-
sponse elements (VDREs) consist of two direct repeats,g–stimulated THP-1 cells had no effect on 1a-hydroxy-
lase mRNA levels. In contrast, 1,25-(OH)2D3 markedly comprised of the consensus sequence AGGTCA, which
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2. Reichel H, Koeffler HP, Norman AW: The role of the vitaminare separated by a 3 bp spacer [36]. However, VDREs
D endocrine system in health and disease. N Engl J Med 320:980–
have also been implicated in negative regulation of gene 991, 1989
3. Girasole G, Wang JM, Pedrazzoni M, Pioli G, Balotta C,expression in the human PTH, chicken PTH, human
Passeri M, Lazzarin A, Ridolfo A, Mantovani A: AugmentationPTH-related peptide, rat PTH-related peptide, human
of monocyte chemotaxis by 1a,25-dihydroxyvitamin D3: Stimula-interleukin-2, and the rat bone sialoprotein genes [37– tion of defective migration of AIDS patients. J Immunol 145:2459–
2464, 199042]. The chicken PTH-negative VDRE is similar to the
4. Cohen MS, Mesler DE, Snipes RG, Gray TK: 1,25-Dihydroxyvi-consensus positive VDRE, except that the last two bases
tamin D3 activates secretion of hydrogen peroxide by human mono-(CA) in the 39-half element are replaced by other nucleo- cytes. J Immunol 136:1049–1053, 1986
5. Rigby WF, Waugh M, Graziano RF: Regulation of human mono-tides (GT). When altering the 39-terminal bases (GT)
cyte HLA-DR and CD4 antigen expression, and antigen presenta-back to the consensus CA, the chicken PTH VDRE
tion by 1,25-dihydroxyvitamin D3. Blood 76:189–197, 1990reverted from a negative to a positive VDRE [43]. In 6. Koren R, Ravid A, Rotem C, Shohami E, Liberman UA, Novo-
grodsky A: 1,25-Dihydroxyvitamin D3 enhances prostaglandin E2the case of the human PTH gene, the negative VDRE
production by monocytes: A mechanism which partially accountscontains a sequence homologous to only one of the two
for the antiproliferative effect of 1,25(OH)2D3 on lymphocytes.hexameric DNA sequences that form the positive FEBS Lett 205:113–116, 1986
7. Tobler A, Gasson J, Reichel H, Norman AW, Koeffler HP:VDRE. It was shown that VDR, but not retinoic acid
Granulocyte-macrophage colony-stimulating factor: Sensitive andX receptor (RXR), was involved in this process, and the
receptor-mediated regulation by 1,25-dihydroxyvitamin D3 in nor-presence of another unknown partner protein(s) of VDR mal human peripheral blood lymphocytes. J Clin Invest 79:1700–
1705, 1987was proposed [44]. These observations led us to speculate
8. Lemire JM, Adams JS, Sakai R, Jordan SC: 1a,25-Dihydroxyvita-that macrophages lack some nuclear proteins binding to
min D3 suppresses proliferation and immunoglobulin productionthe negative VDREs, or some nuclear receptor coactiva- by normal human peripheral blood mononuclear cells. J Clin Invest
74:657–661, 1984tors that could mediate the diverse response of 1,25-
9. Weisman Y, Harell A, Edelstein S, David M, Spirer Z, Go-(OH)2D3. lander A: 1a,25-Dihydroxyvitamin D3 and 24,25-dihydroxyvita-
Macrophage 1a-hydroxylase that causes hypercalce- min D3 in vitro synthesis by human decidua and placenta. Nature
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10. Howard GA, Turner RT, Sherrard DJ, Baylink DJ: Humanregulation of macrophage 1a-hydroxylase has generally bone cells in culture metabolize 25-hydroxyvitamin D3 to 1,25-
been studied by measuring enzymatic activity, but the dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3. J Biol Chem
256:7738–7740, 1981net production of 1,25-(OH)2D3 is determined by both
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lase-mediated inactivation. Since it is difficult to measure chemistry 25:1545–1548, 1986
12. Adams JS, Sharma OP, Gacad MA, Singer FR: Metabolism of 25-1a-hydroxylase activity separate from the effect of other
hydroxyvitamin D3 by cultured pulmonary alveolar macrophages inhydroxylases, the regulation of macrophage 1a-hydroxy- sarcoidosis. J Clin Invest 72:1856–1860, 1983
lase has not been fully elucidated. The molecular cloning 13. Reichel H, Koeffler HP, Barbers R, Norman AW: Regulation
of 1,25-dihydroxyvitamin D3 production by cultured alveolar mac-of 1a-hydroxylase enabled us to investigate the regula-
rophages from normal human donors and from patients with pul-tion at a molecular level. We have shown, to our knowl- monary sarcoidosis. J Clin Endocrinol Metab 65:1201–1209, 1987
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